1990-2021年中国细菌抗微生物药物耐药性负担:2021年全球疾病负担研究的系统分析

IF 8.3 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Yifei Chen, Jinxi Li, Yanhong Gong, Xiaoxv Yin
{"title":"1990-2021年中国细菌抗微生物药物耐药性负担:2021年全球疾病负担研究的系统分析","authors":"Yifei Chen, Jinxi Li, Yanhong Gong, Xiaoxv Yin","doi":"10.1186/s12916-025-04333-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>China is confronted with a severe burden of antimicrobial resistance (AMR), and to date, there has been no comprehensive estimate of the historical trend of the AMR burden in China.</p><p><strong>Methods: </strong>Data on AMR were collected by the Global Antimicrobial Resistance Burden study 1990-2021. Logistic regression, polynomial models, stacked ensemble models, spatiotemporal Gaussian regression models, and mixed-effects meta-regression models are incorporated into the modeling framework to fit the burden of AMR and estimate the number of deaths and disability-adjusted life-years (DALYs) attributable to and associated with AMR in two counterfactual scenarios.</p><p><strong>Results: </strong>In 2021, it was estimated that 711,852 (95% uncertainty interval [UI] (586,447-837,256) deaths were associated with bacterial AMR in China, including 160,268 (132,375-188,160) deaths attributable to bacterial AMR. From 1990 to 2021, the number of deaths attributable to AMR among children under 5 years old declined by 95%, while that among the elderly aged 65 and above increased by 68%. Among the 12 infectious syndromes, the top three with the largest number of deaths attributed to AMR in 2021 were bloodstream infections (74,119), lower respiratory tract infections (60,839), and peritoneal and intra-abdominal infections (11,827). Among them, bloodstream infections were the infectious syndrome with the greatest increase in the number of deaths during the study period. In 2021, the pathogen with the highest number of deaths attributed to AMR was Staphylococcus aureus (39,643), and the one with the greatest increase in attributed deaths was Staphylococcus aureus, with an increase of 20,774 (16,880-24,668). In 2021, the pathogen-drug combination causing the highest number of AMR-attributed deaths was methicillin-resistant Staphylococcus aureus (26,023), and the pathogen with the highest annualized rate of change in attributed deaths over 31 years was third-generation cephalosporin-resistant Acinetobacter baumannii (17.5%).</p><p><strong>Conclusions: </strong>Bacterial antimicrobial resistance in China was a serious threat to public health, especially for elderly people. Meanwhile, intervention measures such as popularizing vaccination, reducing the misuse of antibiotics, and developing new antibiotics should be combined to address this significant health threat.</p>","PeriodicalId":9188,"journal":{"name":"BMC Medicine","volume":"23 1","pages":"517"},"PeriodicalIF":8.3000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12447600/pdf/","citationCount":"0","resultStr":"{\"title\":\"Burden of bacterial antimicrobial resistance 1990-2021 in China: a systematic analysis for the global burden of disease study 2021.\",\"authors\":\"Yifei Chen, Jinxi Li, Yanhong Gong, Xiaoxv Yin\",\"doi\":\"10.1186/s12916-025-04333-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>China is confronted with a severe burden of antimicrobial resistance (AMR), and to date, there has been no comprehensive estimate of the historical trend of the AMR burden in China.</p><p><strong>Methods: </strong>Data on AMR were collected by the Global Antimicrobial Resistance Burden study 1990-2021. Logistic regression, polynomial models, stacked ensemble models, spatiotemporal Gaussian regression models, and mixed-effects meta-regression models are incorporated into the modeling framework to fit the burden of AMR and estimate the number of deaths and disability-adjusted life-years (DALYs) attributable to and associated with AMR in two counterfactual scenarios.</p><p><strong>Results: </strong>In 2021, it was estimated that 711,852 (95% uncertainty interval [UI] (586,447-837,256) deaths were associated with bacterial AMR in China, including 160,268 (132,375-188,160) deaths attributable to bacterial AMR. From 1990 to 2021, the number of deaths attributable to AMR among children under 5 years old declined by 95%, while that among the elderly aged 65 and above increased by 68%. Among the 12 infectious syndromes, the top three with the largest number of deaths attributed to AMR in 2021 were bloodstream infections (74,119), lower respiratory tract infections (60,839), and peritoneal and intra-abdominal infections (11,827). Among them, bloodstream infections were the infectious syndrome with the greatest increase in the number of deaths during the study period. In 2021, the pathogen with the highest number of deaths attributed to AMR was Staphylococcus aureus (39,643), and the one with the greatest increase in attributed deaths was Staphylococcus aureus, with an increase of 20,774 (16,880-24,668). In 2021, the pathogen-drug combination causing the highest number of AMR-attributed deaths was methicillin-resistant Staphylococcus aureus (26,023), and the pathogen with the highest annualized rate of change in attributed deaths over 31 years was third-generation cephalosporin-resistant Acinetobacter baumannii (17.5%).</p><p><strong>Conclusions: </strong>Bacterial antimicrobial resistance in China was a serious threat to public health, especially for elderly people. Meanwhile, intervention measures such as popularizing vaccination, reducing the misuse of antibiotics, and developing new antibiotics should be combined to address this significant health threat.</p>\",\"PeriodicalId\":9188,\"journal\":{\"name\":\"BMC Medicine\",\"volume\":\"23 1\",\"pages\":\"517\"},\"PeriodicalIF\":8.3000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12447600/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12916-025-04333-2\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12916-025-04333-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:中国面临着严重的抗菌素耐药性负担,迄今为止,还没有对中国抗菌素耐药性负担的历史趋势进行全面估计。方法:通过1990-2021年全球抗微生物药物耐药性负担研究收集AMR数据。在建模框架中纳入了逻辑回归、多项式模型、堆叠集成模型、时空高斯回归模型和混合效应元回归模型,以拟合AMR的负担,并估计两种反事实情景中可归因于AMR和与AMR相关的死亡和伤残调整生命年(DALYs)的数量。结果:2021年,中国估计有711,852例(95%不确定区间[UI][586,447-837,256])死亡与细菌性AMR相关,其中160,268例(132,375-188,160)死亡归因于细菌性AMR。从1990年到2021年,5岁以下儿童因抗微生物药物耐药性死亡的人数下降了95%,而65岁及以上老年人的死亡人数增加了68%。在12种感染综合征中,2021年AMR导致的死亡人数最多的前三名是血液感染(74119人)、下呼吸道感染(60839人)、腹膜和腹腔内感染(11827人)。其中,血流感染是研究期间死亡人数增加最多的感染综合征。2021年,因AMR死亡人数最多的病原体是金黄色葡萄球菌(39,643),死亡人数增加最多的病原体是金黄色葡萄球菌,增加了20,774人(16,880-24,668)。2021年,导致抗菌素耐药性死亡人数最多的病原体-药物组合是耐甲氧西林金黄色葡萄球菌(26,023人),31年间死亡人数年化变化率最高的病原体是第三代耐头孢菌素鲍曼不动杆菌(17.5%)。结论:中国细菌耐药性严重威胁公众健康,尤其是老年人。同时,应结合推广疫苗接种、减少抗生素滥用和开发新抗生素等干预措施,应对这一重大健康威胁。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Burden of bacterial antimicrobial resistance 1990-2021 in China: a systematic analysis for the global burden of disease study 2021.

Burden of bacterial antimicrobial resistance 1990-2021 in China: a systematic analysis for the global burden of disease study 2021.

Burden of bacterial antimicrobial resistance 1990-2021 in China: a systematic analysis for the global burden of disease study 2021.

Burden of bacterial antimicrobial resistance 1990-2021 in China: a systematic analysis for the global burden of disease study 2021.

Background: China is confronted with a severe burden of antimicrobial resistance (AMR), and to date, there has been no comprehensive estimate of the historical trend of the AMR burden in China.

Methods: Data on AMR were collected by the Global Antimicrobial Resistance Burden study 1990-2021. Logistic regression, polynomial models, stacked ensemble models, spatiotemporal Gaussian regression models, and mixed-effects meta-regression models are incorporated into the modeling framework to fit the burden of AMR and estimate the number of deaths and disability-adjusted life-years (DALYs) attributable to and associated with AMR in two counterfactual scenarios.

Results: In 2021, it was estimated that 711,852 (95% uncertainty interval [UI] (586,447-837,256) deaths were associated with bacterial AMR in China, including 160,268 (132,375-188,160) deaths attributable to bacterial AMR. From 1990 to 2021, the number of deaths attributable to AMR among children under 5 years old declined by 95%, while that among the elderly aged 65 and above increased by 68%. Among the 12 infectious syndromes, the top three with the largest number of deaths attributed to AMR in 2021 were bloodstream infections (74,119), lower respiratory tract infections (60,839), and peritoneal and intra-abdominal infections (11,827). Among them, bloodstream infections were the infectious syndrome with the greatest increase in the number of deaths during the study period. In 2021, the pathogen with the highest number of deaths attributed to AMR was Staphylococcus aureus (39,643), and the one with the greatest increase in attributed deaths was Staphylococcus aureus, with an increase of 20,774 (16,880-24,668). In 2021, the pathogen-drug combination causing the highest number of AMR-attributed deaths was methicillin-resistant Staphylococcus aureus (26,023), and the pathogen with the highest annualized rate of change in attributed deaths over 31 years was third-generation cephalosporin-resistant Acinetobacter baumannii (17.5%).

Conclusions: Bacterial antimicrobial resistance in China was a serious threat to public health, especially for elderly people. Meanwhile, intervention measures such as popularizing vaccination, reducing the misuse of antibiotics, and developing new antibiotics should be combined to address this significant health threat.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BMC Medicine
BMC Medicine 医学-医学:内科
CiteScore
13.10
自引率
1.10%
发文量
435
审稿时长
4-8 weeks
期刊介绍: BMC Medicine is an open access, transparent peer-reviewed general medical journal. It is the flagship journal of the BMC series and publishes outstanding and influential research in various areas including clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional communities. In addition to research articles, the journal also publishes stimulating debates, reviews, unique forum articles, and concise tutorials. All articles published in BMC Medicine are included in various databases such as Biological Abstracts, BIOSIS, CAS, Citebase, Current contents, DOAJ, Embase, MEDLINE, PubMed, Science Citation Index Expanded, OAIster, SCImago, Scopus, SOCOLAR, and Zetoc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信